Alnylam Pharmaceuticals Inc. reported a smaller second-quarter loss Wednesday as its research and development costs decreased.
View full post on All News, Video and Posts related to SECTOR: Health Care
- Health Law’s New Patient-Centered Outcomes Board Takes Shape; More Insurance Waiver Requests Expected
- Medical Device Manufacturing in the US Industry Market Research Report Now Available from IBISWorld
- Why ObamaCare is Wrong for America: How the New Health Care Law Drives Up Costs, Puts Government in Charge of Your Decisions, and Threatens Your Constitutional Rights
- Raspberry Ketone Lean Advanced Weight Loss Supplement 1200mg 60 Capsules
- health care reform bill pros and cons | Zada News